Xenetic Biosciences, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Xenetic Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Xenetic Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.34M, a 11.6% decline year-over-year.
  • Xenetic Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$5.01M, a 10.7% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$4.52M, a 32.8% increase from 2022.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$6.72M, a 16.9% decline from 2021.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$5.75M, a 58.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.52M +$2.2M +32.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$6.72M -$971K -16.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$5.75M +$8.19M +58.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$13.9M -$1.05M -8.15% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 -$12.9M -$5.61M -77.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$7.28M -$3.71M -104% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$3.57M +$43.9M +92.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 -$47.4M -$37.6M -383% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 -$9.82M +$3.1M +24% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$12.9M -$4.31M -50.1% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 -$8.61M -$2.27M -35.8% Jan 1, 2013 Dec 31, 2013 10-K/A 2015-07-20
2012 -$6.34M Jan 1, 2012 Dec 31, 2012 10-K/A 2015-07-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.